S-Ethylisothiourea Hydrobromide
98%
- Product Code: 110840
Alias:
S-ethylisothiourea bromide; 2-ethylisothiourea hydrobromide
CAS:
1071-37-0
| Molecular Weight: | 185.08 g./mol | Molecular Formula: | C₃H₈N₂SHBr |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00012585 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
S-Ethylisothiourea Hydrobromide is primarily used in biochemical research as a potent inhibitor of nitric oxide synthase (NOS). This application is crucial in studies aimed at understanding the role of nitric oxide in various physiological and pathological processes, including inflammation, neurotransmission, and cardiovascular function. By inhibiting NOS, researchers can explore the effects of reduced nitric oxide production in experimental models, providing insights into potential therapeutic targets for conditions such as septic shock, hypertension, and neurodegenerative diseases. Additionally, it serves as a valuable tool in pharmacological studies to evaluate the efficacy and mechanisms of new drugs targeting nitric oxide pathways. Its use in laboratory settings helps advance the understanding of cellular signaling and the development of novel treatments for nitric oxide-related disorders.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Almost White Powder To Crystal |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 5.000 | 10-20 days | $77.24 |
+
-
|
| 25.000 | 10-20 days | $248.34 |
+
-
|
| 100.000 | 10-20 days | $784.90 |
+
-
|
S-Ethylisothiourea Hydrobromide
S-Ethylisothiourea Hydrobromide is primarily used in biochemical research as a potent inhibitor of nitric oxide synthase (NOS). This application is crucial in studies aimed at understanding the role of nitric oxide in various physiological and pathological processes, including inflammation, neurotransmission, and cardiovascular function. By inhibiting NOS, researchers can explore the effects of reduced nitric oxide production in experimental models, providing insights into potential therapeutic targets for conditions such as septic shock, hypertension, and neurodegenerative diseases. Additionally, it serves as a valuable tool in pharmacological studies to evaluate the efficacy and mechanisms of new drugs targeting nitric oxide pathways. Its use in laboratory settings helps advance the understanding of cellular signaling and the development of novel treatments for nitric oxide-related disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :